The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine

In response to the SARS-CoV-2 Delta variant, which partially escaped the vaccine-induced immunity provided by two doses of vaccination with CoronaVac (Sinovac), the National Vaccine Committee recommended the heterologous CoronaVac-ChAdOx1 (Oxford–AstraZeneca), a prime–boost vaccine regimen. This pil...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahasirimongkol, Surakameth, Khunphon, Athiwat, Kwangsukstid, Oraya, Sapsutthipas, Sompong, Wichaidit, Mingkwan, Rojanawiwat, Archawin, Wichuckchinda, Nuanjun, Puangtubtim, Wiroj, Pimpapai, Warangluk, Soonthorncharttrawat, Sakulrat, Wanitchang, Asawin, Jongkaewwattana, Anan, Srisutthisamphan, Kanjana, Phainupong, Daraka, Thawong, Naphatcha, Piboonsiri, Pundharika, Sawaengdee, Waritta, Somsaard, Thitiporn, Ritthitham, Kanokphon, Chumpol, Supaporn, Pinyosukhee, Nadthanan, Wichajarn, Rattanawadee, Dhepakson, Panadda, Iamsirithaworn, Sopon, Phumiamorn, Supaporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028748/
https://www.ncbi.nlm.nih.gov/pubmed/35455285
http://dx.doi.org/10.3390/vaccines10040536

Ejemplares similares

Ejemplares similares